Hooks J J, Jordan G W, Cupps T, Moutsopoulos H M, Fauci A S, Notkins A L
Arthritis Rheum. 1982 Apr;25(4):396-400. doi: 10.1002/art.1780250406.
Recently, we found interferon in the sera of patients with systemic lupus erythematosus, rheumatoid arthritis, scleroderma, and Sjögren's syndrome. In this study, we surveyed a variety of other immunologically mediated diseases. We did not find interferon in the sera of patients with Wegener's granulomatosis, sarcoidosis, infectious mononucleosis, minimal change nephritis, kidney transplants, myasthenia gravis, or uveitis, but we did find this protein in the sera of patients with active systemic and cutaneous vasculitis. Attempts to characterize the interferon in the sera of patients with systemic lupus erythematosus and vasculitis revealed that antibody to alpha (leukocyte) interferon, but not to beta (fibroblast) interferon, partially or completely neutralized the antiviral activity. The failure of antibody to alpha interferon to completely neutralize the antiviral activity in certain specimens and the lability of the antiviral activity in some specimens to pH 2.0 treatment both suggest that more than one type of interferon was present.
最近,我们在系统性红斑狼疮、类风湿性关节炎、硬皮病和干燥综合征患者的血清中发现了干扰素。在本研究中,我们调查了多种其他免疫介导的疾病。我们在韦格纳肉芽肿病、结节病、传染性单核细胞增多症、微小病变性肾炎、肾移植、重症肌无力或葡萄膜炎患者的血清中未发现干扰素,但在活动性系统性和皮肤血管炎患者的血清中发现了这种蛋白质。对系统性红斑狼疮和血管炎患者血清中的干扰素进行特性鉴定的尝试表明,抗α(白细胞)干扰素的抗体而非抗β(成纤维细胞)干扰素的抗体能部分或完全中和抗病毒活性。抗α干扰素抗体未能完全中和某些标本中的抗病毒活性,以及某些标本中的抗病毒活性对pH 2.0处理不稳定,这两者均表明存在不止一种类型的干扰素。